{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:00:42Z","timestamp":1778886042458,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00228-024-03630-8","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T14:02:13Z","timestamp":1705845733000},"page":"475-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A comparison of the mixed and sequential use of acetaminophen and dexketoprofen in painful vaso-occlusive crises"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-8605","authenticated-orcid":false,"given":"Murat","family":"Ka\u00e7maz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-6358","authenticated-orcid":false,"given":"G\u00fcl","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,21]]},"reference":[{"key":"3630_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","volume":"151","author":"A Ashley-Koch","year":"2000","unstructured":"Ashley-Koch A, Yang Q, Olney RS (2000) Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol 151:839\u2013845","journal-title":"Am J Epidemiol"},{"key":"3630_CR2","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S et al (2013) Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med 10:e1001484","journal-title":"PLoS Med"},{"key":"3630_CR3","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","volume":"122","author":"D Manwani","year":"2013","unstructured":"Manwani D, Frenette PS (2013) Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood 122:3892\u20133898","journal-title":"Blood"},{"key":"3630_CR4","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1177\/15353702211005392","volume":"246","author":"N Conran","year":"2021","unstructured":"Conran N, Embury SH (2021) Sickle cell vaso-occlusion: the dialectic between red cells and white cells. Exp Biol Med (Maywood) 246:1458\u20131472","journal-title":"Exp Biol Med (Maywood)"},{"key":"3630_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.mcna.2016.09.009","volume":"101","author":"S Azar","year":"2017","unstructured":"Azar S, Wong TE (2017) Sickle cell disease: a brief update. Med Clin North Am 101:375\u2013393","journal-title":"Med Clin North Am"},{"key":"3630_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40272-017-0263-z","volume":"20","author":"L Puri","year":"2018","unstructured":"Puri L, Nottage KA, Hankins JS, Anghelescu DL (2018) State of the art management of acute vaso-occlusive pain in sickle cell disease. Paediatr Drugs 20:29\u201342","journal-title":"Paediatr Drugs"},{"key":"3630_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11916-009-0047-4","volume":"13","author":"RE Richard","year":"2009","unstructured":"Richard RE (2009) The management of sickle cell pain. Curr Pain Headache Rep 13:295\u2013297","journal-title":"Curr Pain Headache Rep"},{"key":"3630_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1182\/asheducation-2018.1.493","volume":"2018","author":"S Moerdler","year":"2018","unstructured":"Moerdler S, Manwani D (2018) New insights into the pathophysiology and development of novel therapies for sickle cell disease. Hematology Am Soc Hematol Educ Program 2018:493\u2013506","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3630_CR9","doi-asserted-by":"publisher","first-page":"204062072095500","DOI":"10.1177\/2040620720955000","volume":"11","author":"I Osunkwo","year":"2020","unstructured":"Osunkwo I, Manwani D, Kanter J (2020) Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease. Ther Adv Hematol 11:2040620720955000","journal-title":"Ther Adv Hematol"},{"key":"3630_CR10","first-page":"Cd005406","volume":"7","author":"U Okomo","year":"2017","unstructured":"Okomo U, Meremikwu MM (2017) Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev 7:Cd005406","journal-title":"Cochrane Database Syst Rev"},{"key":"3630_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/PEC.0000000000001976","volume":"36","author":"RP Quarrie","year":"2020","unstructured":"Quarrie RP, Stoner MJ, Choueiki JM et al (2020) Clinical impact of warmed intravenous saline in sickle cell patients with vasoocclusive episodes. Pediatr Emerg Care 36:229\u2013235","journal-title":"Pediatr Emerg Care"},{"key":"3630_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.hoc.2018.01.014","volume":"32","author":"AM Brandow","year":"2018","unstructured":"Brandow AM, DeBaun MR (2018) Key components of pain management for children and adults with sickle cell disease. Hematol Oncol Clin North Am 32:535\u2013550","journal-title":"Hematol Oncol Clin North Am"},{"key":"3630_CR13","doi-asserted-by":"publisher","first-page":"134534","DOI":"10.1016\/j.neulet.2019.134534","volume":"714","author":"CP Carroll","year":"2020","unstructured":"Carroll CP (2020) Opioid treatment for acute and chronic pain in patients with sickle cell disease. Neurosci Lett 714:134534","journal-title":"Neurosci Lett"},{"key":"3630_CR14","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","volume":"4","author":"AM Brandow","year":"2020","unstructured":"Brandow AM, Carroll CP, Creary S et al (2020) American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv 4:2656\u20132701","journal-title":"Blood Adv"},{"key":"3630_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s13312-021-2160-3","volume":"58","author":"PC Panda","year":"2021","unstructured":"Panda PC, Mishra NR, Patra CS et al (2021) Intravenous acetaminophen vs intravenous diclofenac sodium in management of skeletal vaso-occlusive crisis among children with homozygous sickle cell disease: a randomized controlled trial. Indian Pediatr 58:229\u2013232","journal-title":"Indian Pediatr"},{"key":"3630_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/pan.12172","volume":"23","author":"CM Neri","year":"2013","unstructured":"Neri CM, Pestieau SR, Darbari DS (2013) Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease. Paediatr Anaesth 23:684\u2013689","journal-title":"Paediatr Anaesth"},{"key":"3630_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1001\/archpedi.155.4.496","volume":"155","author":"JL Beiter Jr","year":"2001","unstructured":"Beiter JL Jr, Simon HK, Chambliss CR et al (2001) Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Arch Pediatr Adolesc Med 155:496\u2013500","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3630_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ajh.2830460108","volume":"46","author":"E Perlin","year":"1994","unstructured":"Perlin E, Finke H, Castro O et al (1994) Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis. Am J Hematol 46:43\u201347","journal-title":"Am J Hematol"},{"key":"3630_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00006565-199906000-00004","volume":"15","author":"WE Hardwick Jr","year":"1999","unstructured":"Hardwick WE Jr, Givens TG, Monroe KW et al (1999) Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis. Pediatr Emerg Care 15:179\u2013182","journal-title":"Pediatr Emerg Care"},{"key":"3630_CR20","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1182\/blood-2009-06-227330","volume":"114","author":"P Bartolucci","year":"2009","unstructured":"Bartolucci P, El Murr T, Roudot-Thoraval F et al (2009) A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood 114:3742\u20133747","journal-title":"Blood"},{"key":"3630_CR21","doi-asserted-by":"crossref","unstructured":"Shastri N (2015) Intravenous acetaminophen use in pediatrics. Pediatr Emerg Care. 31: 444\u2013448; quiz 449\u2013450.","DOI":"10.1097\/PEC.0000000000000463"},{"key":"3630_CR22","first-page":"5","volume":"44","author":"P Baichoo","year":"2019","unstructured":"Baichoo P, Asuncion A, El-Chaar G (2019) Intravenous acetaminophen for the management of pain during vaso-occlusive crises in pediatric patients. P t 44:5\u20138","journal-title":"P t"},{"key":"3630_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/acem.14149","volume":"28","author":"T Dhebaria","year":"2021","unstructured":"Dhebaria T, Sivitz A, Tejani C (2021) Does intravenous acetaminophen reduce opioid requirement in pediatric emergency department patients with acute sickle cell crises? Acad Emerg Med 28:639\u2013646","journal-title":"Acad Emerg Med"},{"key":"3630_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1515\/sjpain-2017-0140","volume":"18","author":"FA Lubega","year":"2018","unstructured":"Lubega FA, DeSilva MS, Munube D et al (2018) Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial. Scand J Pain 18:19\u201327","journal-title":"Scand J Pain"},{"key":"3630_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/SPC.0000000000000437","volume":"13","author":"L Puri","year":"2019","unstructured":"Puri L, Morgan KJ, Anghelescu DL (2019) Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease. Curr Opin Support Palliat Care 13:402\u2013407","journal-title":"Curr Opin Support Palliat Care"},{"key":"3630_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/acem.14382","volume":"29","author":"MS Alshahrani","year":"2022","unstructured":"Alshahrani MS, AlSulaibikh AH, ElTahan MR et al (2022) Ketamine administration for acute painful sickle cell crisis: a randomized controlled trial. Acad Emerg Med 29:150\u2013158","journal-title":"Acad Emerg Med"},{"key":"3630_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/sjmms.sjmms_218_20","volume":"9","author":"MS Alshahrani","year":"2021","unstructured":"Alshahrani MS, Alghamdi MA (2021) Ketamine for sickle cell vaso-occlusive crises: a systematic review. Saudi J Med Med Sci 9:3\u20139","journal-title":"Saudi J Med Med Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03630-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:07:13Z","timestamp":1708074433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03630-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3630"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03630-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,21]]},"assertion":[{"value":"16 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}